A doctor informs us that he has received the email shown below. The doctor expresses all his disappointment for an init
initiative of the kind which, according to him, represents not only a lack of sensitivity at least in a moment like this of health emergency, but also a completely inappropriate initiative and a looting operation. The doctor asks us if everything is legal as they say.
egr. Doctor, obviously there is nothing legal in operations of this kind simply because it is a marketing operation whose purpose is the monitoring of scientific information. How is, or at least should, be known the scientific information of the drug according to the art. 122 and 126 of Legislative Decree 219/06 depends on a scientific service independent of marketing and on which marketing cannot carry out any control. Anonymity is alone 
formal, it is enough to know who the participating doctors are and it is easy to trace the ISF thus configuring a violation of law 300 of 1970 for improper control of work activity. It is also a violation of the Emilia Romagna regional application on scientific information.
In a moment of coronavirus health emergency, leaving aside the sensitivity that is a utopia for people like this, all the doctors are totally taken and busy dealing with the emergency, something like this disturbs (to be good) at least a service of public necessity or utility (art. 340 criminal code). And if we want to talk about our opinion, at a time like this things like this are a shame for human beings. Let's hope it's a hoax!
Dear Dr. / Dr
IQVIA ( www.iqvia.com ) is pleased to invite you to the new international study on Pharmaceutical Promotion called:
Channel dynamics
Even though our country is in such a difficult time, IQVIA continues with its mission: To help improve the healthcare pharmaceutical sector through analysis and research.
This study, in which a limited number of doctors in 38 countries worldwide participates, has the purpose of monitoring scientific information.
The methods of participation are very simple and fast: when you receive promotional information (this month by telephone and by mail due to anti-coronavirus measures) from pharmaceutical companies, it will be sufficient to fill in short online questionnaires, using the link we will provide. In this study, the name of the participating doctor and the data entered are processed in compliance with anonymity and with the rules on the protection of personal data of the new EU Regulation 2016/679.
INCENTIVES
To thank you for your kind cooperation, at the end of each quarter, you will receive a gift of your choice among different products such as:
· Mondadori magazines: Annual or six-monthly subscriptions to all magazines currently on sale.
· Enogastronomic Products: Compositions of baskets of your choice.
· Gift card: Books, films, music for products: Amazon, Feltrinelli, Mondadori. Home and fashion related to the brands: Coin, Zalando, KASANOVA, Piquadro. IT and household appliances purchasable on: Amazon, Euronics, MediaWorld, TRONY, Apple, Microsoft. Travel, Sport and Leisure related to purchases on: Ryanair and Decathlon
· Telephone top-ups: TIM, TRE, VODAFONE, PosteMobile, WIND, FastWeb, COOPVoce.
CONFIRM PARTICIPATION
If available to participate, please reply to this email indicating:
Specialty he is currently practicing with
Telephone number (essential for any important communications)
· Average of the visits of the informants that it receives monthly
Once we receive your confirmation, we will send you all the information you need to start participating.
Waiting for your reply, we send you our best regards.
Learn more about IQVIA™
The official Docnet app is available in the App Store and Google Play Get it on Google Play
We assure you that we comply with applicable laws and regulations, including those relating to the protection of personal data, as well as the British Healthcare Business Intelligence Association (BHBIA), Market Research Society (MRS), European Pharmaceutical Marketing Research Association (EphMRA ) and codes and ESOMAR Market Research Guidelines.
Your responses, and any personal information you provide in completing our surveys, will be processed by the IQVIA group of companies (“IQVIA”) on a need-to-know basis, for the purpose of informing IQVIA and its customers of current business trends pharmaceutical industry promotions and for the limited contact purposes specified below. Your responses may also be used by IQVIA to create non-identifiable information, which we may use alone or in combination with information obtained from other sources, to gain insights into this area.
We may contact you again for quality control purposes and/or to explore your interest in participating in additional IQVIA oncology-related studies, including clinical trials.
Participating in this market research does not constitute an incentive to prescribe, supply, administer, recommend, buy or sell any drug.
You can withdraw from market research at any time. If you wish to withdraw your consent to our processing of your personal information as described herein, please write to english@es.imshealth.com
______________
